Alzheimer's Disease Trial, Recruiting (NCT05730023)

Alzheimer's Disease Trial, Recruiting NCT05730023 Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05730023 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

People who have been diagnosed with Primary Progressive Aphasia (PPA), a condition that gradually affects language and communication, based on current medical guidelines.
People whose PPA is considered mild, as measured by a specific language assessment tool called the Progressive Aphasia Severity Scale (PASS).
People whose first and main language is Italian.

Who may not be able to join:

People who have a developmental disorder (such as conditions affecting learning or development from an early age).
People who have a medical or psychiatric condition that could make it difficult to complete the study's assessments and tests.
People who have a medical condition that makes a brain stimulation technique called tDCS (a non-invasive procedure that uses mild electrical currents) unsafe for them (confirm with trial site for specific details).

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria Cotelli, IRCCS Istituto Centro San Giovanni di Dio- Fatebenefratelli

Phone: 00390303501457

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05730023

Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 00390303501457

More information: https://clinicaltrials.gov/study/NCT05730023

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

People who have been diagnosed with Primary Progressive Aphasia (PPA), a condition that gradually affects language and communication, based on current medical guidelines.
People whose PPA is considered mild, as measured by a specific language assessment tool called the Progressive Aphasia Severity Scale (PASS).
People whose first and main language is Italian.

Who may not be able to join:

People who have a developmental disorder (such as conditions affecting learning or development from an early age).
People who have a medical or psychiatric condition that could make it difficult to complete the study's assessments and tests.
People who have a medical condition that makes a brain stimulation technique called tDCS (a non-invasive procedure that uses mild electrical currents) unsafe for them (confirm with trial site for specific details).

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Centro San Giovanni di Dio Fatebenefratelli

Registry

ClinicalTrials.gov

Start date

1 February 2023

Est. completion

1 January 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in measure of naming as assessed by International Picture Naming Project Task (IPNP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov